News | September 26, 2023
Briefs: Mankind Pharma and Sequent Scientific
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team
The companies will work with investigators to share the results with the scientific community
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Patient Advisory Councils (PACs) to be set up across hospitals to make patients true partners in enhancing patient safety and improving care delivery
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
Subscribe To Our Newsletter & Stay Updated
